Quantbot Technologies LP Acquires 18,860 Shares of Humana Inc. $HUM

Key Points

• Quantbot Technologies LP significantly increased its stake in Humana Inc. by 1,453% in the first quarter, holding 20,158 shares worth approximately $5.33 million.
• Several hedge funds have also adjusted their positions, with institutional investors now owning 92.38% of Humana's stock.
• Recent research reports resulted in a majority of analysts rating the stock as "Hold," with a consensus target price of $281.43.

Quantbot Technologies LP increased its holdings in Humana Inc. (NYSE:HUM - Free Report) by 1,453.0% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 20,158 shares of the insurance provider's stock after purchasing an additional 18,860 shares during the period. Quantbot Technologies LP's holdings in Humana were worth $5,334,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the business. Vanguard Group Inc. boosted its stake in shares of Humana by 8.9% during the 1st quarter. Vanguard Group Inc. now owns 13,972,872 shares of the insurance provider's stock worth $3,697,222,000 after acquiring an additional 1,143,662 shares in the last quarter. Pzena Investment Management LLC raised its stake in shares of Humana by 6.1% in the 1st quarter. Pzena Investment Management LLC now owns 3,828,923 shares of the insurance provider's stock valued at $1,013,133,000 after acquiring an additional 219,541 shares in the last quarter. Davis Selected Advisers lifted its holdings in Humana by 3.3% in the 1st quarter. Davis Selected Advisers now owns 2,331,343 shares of the insurance provider's stock worth $616,873,000 after purchasing an additional 74,434 shares during the last quarter. T. Rowe Price Investment Management Inc. boosted its position in Humana by 11.1% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 1,605,771 shares of the insurance provider's stock worth $407,401,000 after purchasing an additional 160,952 shares during the period. Finally, Northern Trust Corp boosted its position in Humana by 14.5% during the fourth quarter. Northern Trust Corp now owns 1,216,195 shares of the insurance provider's stock worth $308,561,000 after purchasing an additional 153,739 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the stock. Robert W. Baird dropped their price target on shares of Humana from $300.00 to $297.00 and set a "neutral" rating on the stock in a research report on Friday, July 25th. Royal Bank Of Canada lifted their target price on shares of Humana from $283.00 to $322.00 and gave the stock an "outperform" rating in a report on Thursday. Oppenheimer boosted their target price on shares of Humana from $300.00 to $310.00 and gave the stock an "outperform" rating in a research report on Thursday, May 1st. Wells Fargo & Company lowered their price target on Humana from $348.00 to $344.00 and set an "overweight" rating on the stock in a research report on Thursday, August 14th. Finally, Cantor Fitzgerald reissued a "neutral" rating and set a $290.00 price objective on shares of Humana in a research report on Thursday, May 1st. Seven investment analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the stock. According to data from MarketBeat, Humana presently has a consensus rating of "Hold" and an average price target of $283.29.

Humana Stock Performance

Shares of NYSE HUM traded up $4.2280 during trading hours on Thursday, reaching $294.2280. The stock had a trading volume of 1,471,312 shares, compared to its average volume of 1,866,874. The company has a market cap of $35.39 billion, a price-to-earnings ratio of 22.58, a PEG ratio of 1.71 and a beta of 0.44. Humana Inc. has a twelve month low of $206.87 and a twelve month high of $382.72. The business's fifty day moving average is $247.28 and its two-hundred day moving average is $253.70. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). The company had revenue of $32.39 billion for the quarter, compared to analyst estimates of $31.85 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. The firm's revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, research analysts expect that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.2%. Humana's dividend payout ratio (DPR) is presently 27.17%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.